Delving into the Latest Updates on Dan Dong Yi Chuang Yao Ye You Xian Ze Ren Gong Si with Synapse

Overview

Tags

Nervous System Diseases

Cardiovascular Diseases

Respiratory Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	3
Infectious Diseases	2
Immune System Diseases	2

Top 5 Drug Type	Count

Small molecule drug	5

Top 5 Target	Count

COX(Cyclooxygenases)	2
TXA2 synthase(Thromboxane A2 synthase)	1
A1R x A2bR x PDE	1

[Translation] A single-dose, randomized, open-label, two-period, double-crossover bioequivalence study of metformin hydrochloride tablets (0.25 g) produced by Dandong Yichuang Pharmaceutical Co., Ltd. and metformin hydrochloride tablets (trade name: Glycoran, 0.25 g) certified by NIPPON SHINYAKU CO., LTD. in healthy subjects under fasting and fed conditions

主要研究目的：以NIPPON SHINYAKU CO.,LTD.持证的盐酸二甲双胍片（商品名：Glycoran）为参比制剂，以丹东医创药业有限责任公司生产的盐酸二甲双胍片为受试制剂，通过单中心、随机、开放、单次给药、两周期、双交叉临床研究来评价两种制剂的人体生物等效性。次要研究目的：观察受试制剂和参比制剂在中国健康受试者中的安全性。

[Translation]

The main purpose of the study is to use the metformin hydrochloride tablets (trade name: Glycoran) certified by NIPPON SHINYAKU CO., LTD. as the reference preparation and the metformin hydrochloride tablets produced by Dandong Yichuang Pharmaceutical Co., Ltd. as the test preparation to evaluate the bioequivalence of the two preparations in humans through a single-center, randomized, open, single-dose, two-cycle, double-crossover clinical study. Secondary purpose of the study: To observe the safety of the test preparation and the reference preparation in healthy Chinese subjects.

Start Date-

Sponsor / Collaborator

Dan Dong Yi Chuang Yao Ye You Xian Ze Ren Gong Si

100 Clinical Results associated with Dan Dong Yi Chuang Yao Ye You Xian Ze Ren Gong Si

Login to view more data

0 Patents (Medical) associated with Dan Dong Yi Chuang Yao Ye You Xian Ze Ren Gong Si

Login to view more data

1

Literatures (Medical) associated with Dan Dong Yi Chuang Yao Ye You Xian Ze Ren Gong Si

Zhongguo Xiandai Zhongyao

Research progress in Dioscorea bulbifera

Author: Gao, Wang ; Huang, Ji-peng ; Gao, Hui-yuan

A review.This paper reviewed the research progress on chem. components including steroids, diterpenoid lactones, flavones, phenols, organic acid compound, alkaloids, saccharides, and glycosides, pharmaceutical activity such as anticancer effect, antibacterial effect, acesodyne function, and anti-inflammatory function, clinic application, etc. of Dioscorea bulbifera.

100 Deals associated with Dan Dong Yi Chuang Yao Ye You Xian Ze Ren Gong Si

Login to view more data

100 Translational Medicine associated with Dan Dong Yi Chuang Yao Ye You Xian Ze Ren Gong Si

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

5

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Theophylline Sodium Glycinate ( A1R x A2bR x PDE )	Pulmonary Edema More	Approved
Ozagrel Sodium ( TXA2 synthase )	Cerebrovascular Disorders More	Approved
Diisopropylamine Dichloroacetate	Chronic liver disease More	Approved
Ibuprofen ( COX )	Fever More	Approved
Acetaminophen ( COX )	Pain More	Approved